PCRX
Pacira Biosciences, Inc.
$25.37-0.18 (-0.70%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
Insider Activity
7 of 66 tradesExecutives investing their own money
🤖 AI InsightHaiku 4.5
Pacira BioSciences, Inc. (PCRX) is a publicly traded company with 26 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 7 unique insiders. All recorded transactions were sales totaling $286K. Note that insider selling can occur for many reasons (diversification, tax planning, pre-scheduled 10b5-1 plans) and is not always a bearish signal. All data below is sourced directly from public SEC EDGAR Form 4 filings.
Latest Insider Transactions
Showing 10 of 66 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-25 | 2026-04-23 | Cross Shawn | CFO | Exercise Conversion | 12,941 | $16.45 | $212,879 | N/A | N/A |
| 2026-04-25 | 2026-04-23 | Cross Shawn | CFO | Sale | 12,941 | $25.16 | $325,596 | N/A | N/A |
| 2026-04-25 | 2026-04-23 | Cross Shawn | CFO | Exercise Conversion | 12,941 | $16.45 | $212,879 | N/A | N/A |
| 2026-04-23 | 2026-04-22 | Cross Shawn | CFO | Exercise Conversion | 1,500 | $0.00 | $0 | N/A | N/A |
| 2026-04-23 | 2026-04-22 | Cross Shawn | CFO | Sale | 1,500 | $25.01 | $37,515 | N/A | N/A |
| 2026-04-23 | 2026-04-22 | Cross Shawn | CFO | Exercise Conversion | 1,500 | $16.45 | $24,675 | N/A | N/A |
| 2026-04-23 | 2026-04-21 | Cross Shawn | CFO | Exercise Conversion | 2,845 | $0.00 | $0 | N/A | N/A |
| 2026-04-23 | 2026-04-21 | Cross Shawn | CFO | Sale | 2,845 | $25.01 | $71,153 | N/A | N/A |
| 2026-04-23 | 2026-04-21 | Cross Shawn | CFO | Exercise Conversion | 2,845 | $16.45 | $46,800 | N/A | N/A |
| 2026-04-23 | 2026-04-20 | Cross Shawn | CFO | Exercise Conversion | 7,714 | $0.00 | $0 | N/A | N/A |
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.